oncobiotix
Contact

Let's make microbiome
biology a drug.

We welcome conversations with partners across the cancer-immunotherapy field. Reach out for the clinical development plan or a deeper walk through the science.

Partnering & business development

Dr. David Stojdl, Chief Executive Officer. For partnering across the cancer-immunotherapy field and scientific discussion.

Email us
What you can request
  • The data package. Our full preclinical data, shared under confidentiality.
  • The clinical plan. The first trial design and development timeline.
  • A science deep-dive. A working session on how OBX34 works and where it's headed.
Headquarters
Calgary, Canada
Entity
Oncobiotix Inc.
Explore the science